HCA Healthcare (HCA) AI Stock Analysis

• Market Cap: $107.93B
• Dividend Yield: 0.61%
• Average Volume (3M): 1.29M
• Price to Earnings (P/E): 18.3
• Beta (1Y): 0.37
• Revenue Growth: 6.82%
• EPS Growth: 15.82%
• Country: US
• Employees: 226,000
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 6.96
• Shares Outstanding: 228,193,900
• 10 Day Avg. Volume: 1,280,333
• 30 Day Avg. Volume: 1,285,083
• PEG Ratio: 0.86
• Price to Book (P/B): -31.06
• Price to Sales (P/S): 1.10
• P/FCF Ratio: 13.76
• Enterprise Value/Market Cap: 1.38
• Enterprise Value/Revenue: 2.00
• Enterprise Value/Gross Profit: 12.78
• Enterprise Value/Ebitda: 9.91
• 1Y Price Target: $484.56
• Price Target Upside: 2.45% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 19
• EPS Forecast (FY): 27.68
• Revenue Forecast (FY): $75.67B

• Rating: 70 Neutral
• Price Target: $532.00 ▲(12.48% Upside)

HCA Healthcare's strong earnings call performance and positive technical indicators are key strengths, driving the overall score. However, financial risks from high leverage and a low dividend yield moderate the score.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand and effective business strategies, enhancing HCA's market position and financial stability.

Operational Efficiency

Improved operational efficiency through cost management enhances profitability, supporting sustainable long-term growth.

Cash Flow Management

Strong cash flow management ensures liquidity and financial flexibility, enabling strategic investments and debt servicing.

Negative Factors

High Debt Levels

High debt levels can strain financial resources and limit strategic options, posing risks to long-term financial health.

Federal Policy Uncertainty

Policy uncertainty can impact revenue streams and operational planning, creating potential volatility in healthcare service demand.

Hurricane-Impacted Markets

Ongoing challenges in hurricane-impacted markets can hinder recovery and growth, affecting regional performance and resource allocation.

HCA Healthcare Business Overview & Revenue Model

Company Description

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

How the Company Makes Money

HCA Healthcare generates revenue primarily through patient services provided at its hospitals and outpatient facilities. The key revenue streams include inpatient admissions, outpatient services, surgical procedures, emergency room visits, and diagnostic imaging. The company is largely funded by third-party payers such as Medicare, Medicaid, and private insurance companies, which reimburse HCA for the medical services rendered. Additionally, HCA benefits from partnerships with various healthcare organizations and has implemented strategies to optimize operational efficiency, reduce costs, and enhance patient care, contributing to its overall earnings. The company also invests in technology and data analytics to improve service delivery and patient outcomes, further supporting its revenue generation efforts.

HCA Healthcare Financial Statement Overview

Summary

HCA Healthcare shows strong revenue growth and cash flow management, with a TTM revenue growth rate of 2.3% and a free cash flow growth rate of 11%. However, the high debt-to-equity ratio and negative stockholders' equity present significant financial risks.

Income Statement

HCA Healthcare shows a consistent revenue growth trend, with a TTM revenue growth rate of 2.3%. The company maintains stable profitability with a gross profit margin of 15.6% and a net profit margin of 8.5%. However, margins have slightly decreased compared to previous years, indicating potential pressure on profitability.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio due to negative stockholders' equity, which poses a significant risk. The return on equity is negative, reflecting challenges in generating returns for shareholders. Despite these concerns, the company has substantial total assets, indicating potential for future leverage.

Cash Flow

HCA Healthcare demonstrates strong cash flow management with a free cash flow growth rate of 11% TTM. The operating cash flow to net income ratio is healthy at 0.72, indicating efficient cash generation relative to profits. The free cash flow to net income ratio of 0.63 further supports the company's robust cash flow position.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	74.37B	70.60B	64.97B	60.23B	58.75B	51.53B
Gross Profit	11.63B	10.55B	9.63B	9.05B	9.68B	7.26B
EBITDA	15.00B	13.90B	12.72B	13.29B	14.21B	9.71B
Net Income	6.38B	5.76B	5.24B	5.64B	6.96B	3.75B
Balance Sheet
Total Assets	59.75B	59.51B	56.21B	52.44B	50.74B	47.49B
Cash, Cash Equivalents and Short-Term Investments	997.00M	2.02B	935.00M	908.00M	1.45B	1.79B
Total Debt	46.35B	45.24B	41.86B	40.20B	36.73B	33.06B
Total Liabilities	61.91B	58.96B	55.15B	52.51B	49.25B	44.60B
Stockholders Equity	-5.33B	-2.50B	-1.77B	-2.77B	-933.00M	572.00M
Cash Flow
Free Cash Flow	8.10B	5.64B	4.69B	4.13B	5.38B	6.40B
Operating Cash Flow	12.84B	10.51B	9.43B	8.52B	8.96B	9.23B
Investing Cash Flow	-5.02B	-4.93B	-5.32B	-3.39B	-2.64B	-3.39B
Financing Cash Flow	-9.71B	-4.58B	-4.09B	-5.66B	-6.66B	-4.68B

HCA Healthcare Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 472.98
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCA, the sentiment is Positive. The current price of 472.98 is below the 20-day moving average (MA) of 487.60, above the 50-day MA of 467.46, and above the 200-day MA of 394.64, indicating a neutral trend. The MACD of -0.19 indicates Positive momentum. The RSI at 47.30 is Neutral, neither overbought nor oversold. The STOCH value of 31.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HCA.

HCA Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UHS	74 Outperform	$14.21B	10.81	19.97%	0.36%	10.21%	39.58%
THC	74 Outperform	$17.25B	13.46	34.51%	―	-0.56%	-53.50%
HCA	70 Neutral	$107.93B	18.28	―	0.61%	6.82%	15.82%
FMS	65 Neutral	$13.73B	17.06	5.31%	3.35%	4.09%	13.17%
EHC	64 Neutral	$10.70B	20.11	24.94%	0.66%	11.13%	27.53%
DVA	59 Neutral	$8.13B	11.86	―	―	5.14%	4.37%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

HCA Healthcare Corporate Events

HCA Healthcare Issues $3.25 Billion in Senior Notes

On October 31, 2025, HCA Inc., a subsidiary of HCA Healthcare, completed a significant financial transaction by issuing $3.25 billion in senior notes. This issuance, which includes notes maturing between 2030 and 2055, is expected to impact the company’s financial operations by providing additional capital, potentially influencing its market positioning and stakeholder interests.

HCA Healthcare Announces Senior Notes Offering

On October 27, 2025, HCA Healthcare announced a proposed public offering of senior unsecured notes through its subsidiary, HCA Inc. The proceeds from this offering are intended for general corporate purposes, including the potential redemption of $1.5 billion of senior notes due in 2026. This strategic financial move is expected to impact HCA’s financial operations and market positioning by potentially reducing its debt obligations.

HCA Healthcare Reports Strong Q3 2025 Financial Results

HCA Healthcare reported strong financial results for the third quarter of 2025, with revenues increasing by 9.6% to $19.161 billion and net income rising by 29.4% to $1.643 billion compared to the same period in 2024. The company also announced a quarterly cash dividend of $0.72 per share, payable on December 29, 2025, and raised its 2025 financial guidance, reflecting a positive outlook for stakeholders.